SCOPUS 정보 검색 플랫폼

Volumn 7, Issue 2, 2001, Pages 255-258

The toxicity of deglycosylated ricin a chain-containing immunotoxins in patients with non-Hodgkin’s lymphoma is exacerbated by prior radiotherapy: A retrospective analysis of patients in five clinical trials

(5) Schindler, John a Sausville, Edward b Messmann, Richard b Uhr, Jonathan W a Vitetta, Ellen S a

a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER (United States)

b NATIONAL CANCER INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOTOXIN; RICIN A;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CELL KILLING; DEGLYCOSYLATION; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; GENE TARGETING; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TARGET CELL;

ADULT; AGED; AGED, 80 AND OVER; CAPILLARY LEAK SYNDROME; CLINICAL TRIALS; FEMALE; HUMANS; IMMUNOTOXINS; LYMPHOMA, NON-HODGKIN; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; RETROSPECTIVE STUDIES; RICIN;

EID: 0035126881 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (47)

References (16)

1
- 0006097095
- Immunotoxin therapy: Past lessons and future direction
- M. L. Grossbard (ed). Boston: Marcel Dekker, Inc.
- (1997) Monoclonal Antibody-based Theraphy of Cancer , pp. 417-432
- Vitetta, E.S.¹ Ghetie, M.A.² Ghetie, V.³

2
- 0001952465
- Immunotoxins
- K. F. Austen, S. J. Burakoff, F. S. Rosen, T. B. Strom (eds.). Blackwell Science, Inc.
- (1996) Therapuetic Immunology , pp. 385-397
- Thrush, G.R.¹ Lark, L.R.² Vitetta, E.S.³

3
- 0024207837
- Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas
- (1988) Int. J. Cancer , vol.42 , pp. 792-797
- Shen, G.-L.¹ Li, J.-L.² Ghetie, M.-A.³ Ghetie, V.⁴ May, R.D.⁵ Till, M.⁶ Brown, A.N.⁷ Relf, M.⁸ Knowles, P.⁹ Uhr, J.W.¹⁰ Janossy, G.¹¹ Amlot, P.¹² Vitetta, E.S.¹³ Thorpe, P.E.¹⁴

4
- 0023886893
- Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B- cells as potential reagents for in vivo therapy
- (1988) Cancer Res. , vol.48 , pp. 2610-2617
- Ghetie, M.-A.¹ May, R.D.² Till, M.³ Uhr, J.W.⁴ Ghetie, V.⁵ Knowles, P.P.⁶ Relf, M.⁷ Brown, A.⁸ Wallace, P.M.⁹ Janossy, G.¹⁰ Amlot, P.¹¹ Vitetta, E.S.¹² Thorpe, P.E.¹³

5
- 0006026377
- Expression of cytoplasmic CD22 in B cell ontogeny
- A. J. McMichael (ed.), Leukocyte Typing III. Oxford: Oxford University Press
- (1987) , pp. 474-476
- Dorken, B.¹ Pezzutto, A.² Kohler, M.³

6
- 0001390458
- B cell differentiation antigens identified by monoclonal antibodies (HD6, HD28, HD37, HD39)
- (1983) Immunobiology , vol.165 , pp. 253-254
- Dörken, B.¹ Moldenhauer, G.² Schwartz, R.³ Pezzutto, A.⁴ Hammerling, G.⁵

7
- 0023100497
- Properties of IT-dgA effect of chemical deglycosylation of ricin A-chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A-chain and anti-Thy 1.1 antibody
- (1987) Cancer Res. , vol.47 , pp. 947-952
- Blakely, D.C.¹ Watson, G.J.² Knowles, P.P.³ Thorpe, P.E.⁴

8
- 0033970088
- The combined use of an immunotoxin and a radioimmunoconjugate to treat disseminated human B cell lymphoma in immunodeficient mice
- (2000) Clin. Cancer Res. , vol.6 , pp. 631-642
- Wei, B.-R.¹ Ghetie, M.-A.² Vitetta, E.S.³

9
- 0034092593
- A phase I study of combination therapy with immunotoxins IgG-HD37-dgA and IgG-RFB4-dgA (Combotox) in patients with refractory CDI9(+). CD22(+) B-cell lymphoma
- (2000) Clin. Cancer Res. , vol.6 , pp. 1302-1313
- Messmann, R.A.¹ Vitetta, E.S.² Headlee, D.³ Senderowicz, A.M.⁴ Figg, W.D.⁵ Schindler, J.⁶ Michiel, D.F.⁷ Creekmore, S.⁸ Steinberg, S.M.⁹ Kohler, D.¹⁰ Jaffe, E.S.¹¹ Stetler-Stevenson, M.¹² Chen, H.¹³ Ghetie, V.¹⁴ Sausville, E.A.¹⁵

10
- 0027374447
- A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy
- (1993) Blood , vol.82 , pp. 2624-2633
- Amlot, P.L.¹ Stone, M.J.² Cunningham, D.³ Fay, J.⁴ Newman, J.⁵ Collins, R.⁶ May, R.⁷ McCarthy, M.⁸ Richardson, J.⁹ Ghetie, V.¹⁰ Ramilo, O.¹¹ Thorpe, P.E.¹² Uhr, J.W.¹³ Vitetta, E.S.¹⁴

11
- 0029056665
- Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: A phase I study
- (1995) Blood , vol.85 , pp. 3457-3465
- Sausville, E.A.¹ Headlee, D.² Stetler-Stevenson, M.³ Jaffe, E.S.⁴ Solomon, D.⁵ Figg, W.D.⁶ Herdt, J.⁷ Kopp, W.C.⁸ Rager, H.⁹ Steinberg, S.M.¹⁰ Ghetie, V.¹¹ Schindler, J.¹² Uhr, J.¹³ Wittes, R.E.¹⁴ Vitetta, E.S.¹⁵

12
- 9444268741
- A phase I study of bolus versus continuous infusion of the anti-CDl9 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma
- (1996) Blood , vol.88 , pp. 1188-1197
- Stone, M.J.¹ Sausville, E.A.² Fay, J.W.³ Headlee, D.⁴ Collins, R.H.⁵ Figg, W.D.⁶ Stetler-Stevenson, M.⁷ Jain, V.⁸ Jaffe, E.S.⁹ Solomon, D.¹⁰ Lush, R.M.¹¹ Senderowicz, A.¹² Ghetie, V.¹³ Schindler, J.¹⁴ Uhr, J.W.¹⁵ Vitetta, E.S.¹⁶

13
- 0024437527
- The response of the microvascular system to radiation: A review
- (1989) Cancer Invest. , vol.7 , pp. 287-294
- Baker, D.G.¹ Krochak, R.J.²

14
- 0030158783
- Fibronectin inhibits the cytotoxic effect of ricin A chain on endothelial cells
- (1996) Int. J. Immunopharmacol. , vol.18 , pp. 355-361
- Baluna, R.¹ Ghetie, V.² Oppenheimer-Marks, N.³ Vitetta, E.S.⁴

15
- 0033616693
- Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome
- (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 3957-3962
- Baluna, R.¹ Rizo, J.² Gordon, B.E.³ Ghetie, V.⁴ Vitetta, E.S.⁵

16
- 0034255636
- The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: Insights into toxin-mediated vascular damage
- (2000) Exp. Cell Res. , vol.258 , pp. 417-424
- Baluna, R.¹ Coleman, E.² Jones, C.³ Ghetie, V.⁴ Vitetta, E.S.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.